Duke B B - OmicsDI

Show results for

Unknown (8783)
Transcriptomics (222)
Genomics (139)
Proteomics (94)
Genomic (24)
Metabolomics (6)
Models (5)
Clinical (1)

Organisms

Homo sapiens (198)
Mus musculus (55)
Rattus norvegicus (9)
Caenorhabditis elegans (5)
Cryptococcus neoformans (5)
Drosophila melanogaster (5)
Saccharomyces cerevisiae (5)
Escherichia coli (4)
Arabidopsis thaliana (3)
Olavius algarvensis (3)
Olavius algarvensis Delta 1 endosymbiont (3)
Olavius algarvensis Delta 4 endosymbiont (3)
Olavius algarvensis Gamma 1 endosymbiont (3)
Mammalia (2)
Strongylocentrotus purpuratus (2)
Danio rerio (2)
cellular organisms (1)
Clavispora lusitaniae (1)
Gossypium barbadense (1)
Cryptococcus gattii (1)
Taeniopygia guttata (1)
Zika virus (1)
Brassica napus (1)
Rattus rattus (1)
Mycobacterium tuberculosis (1)
Gallus gallus (1)
Sus scrofa (1)
Eremophila rugosa (1)
108887 (1)
Lycium barbarum (1)

Organisms

Homo sapiens (45)
Mus musculus (24)
synthetic construct (6)
Macaca mulatta (3)
Arabidopsis thaliana (2)
Saccharomyces cerevisiae (2)
Papio cynocephalus (1)
Cryptococcus deneoformans (1)
Pseudomonas syringae (1)
Halobacterium salinarum NRC-1 (1)
Mycobacterium tuberculosis (1)
Ovis aries (1)
Gallus gallus (1)

Repository

biostudies-arrayexpress (250)
ENA (106)
pride (65)
dbGaP (24)
MassIVE (18)
EGA (6)
jPOST (6)
BioModels (5)
MetaboLights (5)
iProX (2)
PanoramaPublic (2)
GNPS (1)

Tissue

Cell culture (15)
Epithelial cell (5)
Brain (4)
Permanent cell line cell (4)
Heart (3)
Liver (3)
Blood plasma (2)
Fibroblast (2)
HeLa cell (2)
Skeletal muscle (2)
Blood (1)
Blood cell (1)
Cell suspension culture (1)
Choroid (1)
Choroidal cell of the eye (1)
Colon (1)
Dendritic cell (1)
Early embryonic cell (1)
Exoskeleton (1)
Hepatocyte (1)
Ovary (1)
Photoreceptor layer of retina (1)
Primary cell (1)
Retinal rod (1)
Skin (1)
Stem cell (1)
Type B pancreatic cell (1)

Disease

Breast cancer (6)
Disease free (3)
Prostate carcinoma (2)
Malignant neoplasm of ovary (2)
Non-small cell lung carcinoma (2)
Prostate adenocarcinoma (2)
Multiple sclerosis (1)
Healthy (1)
Melanoma (1)
Prostate cancer (1)
Dukes C and High Risk Dukes B Colorectal Cancer (1)
Cervix carcinoma (1)
Colon cancer (1)
Degeneration of macula and posterior pole (1)
Obesity (1)
Parkinson's disease (1)
Progeria (1)
Type 2 diabetes mellitus (1)

Technology Type

Mass Spectrometry (65)
Shotgun proteomics (36)
Bottom-up proteomics (17)
Affinity purification coupled with mass spectrometry proteomics (7)
Gel-based experiment (6)
Data-dependent acquisition (4)
Mass spectrometry assay (3)
Mass spectrometry (2)
Data-independent acquisition (1)
HDMSE (1)
SWATH MS (1)
Top-down proteomics (1)

Instrument Platform

Orbitrap Fusion Lumos (6)
Q Exactive (5)
Illumina NovaSeq 6000 (3)
Illumina HiSeq 2000 (3)
NextSeq 500 (3)
Orbitrap Exploris 480 (3)
Liquid Chromatography MS - negative - reverse phase (3)
Liquid Chromatography MS - positive - reverse phase (3)
Illumina HiSeq 2500 (2)
Liquid Chromatography MS - alternating - hilic (2)
Illumina-compatible library preparation equipment (1)
Monarch RNA purification column system (1)
Standard mammalian cell culture equipment (1)
MouseWG-6_V2_0_R3_11278593_A (1)
Illumina MiSeq (1)
NextSeq 550 (1)
Illumina HiSeq 4000 (1)
MicrOTOF II (1)
Orbitrap Astral (1)
Orbitrap Fusion ETD (1)
Q-exactive (1)
Thermo Exploris 480 (1)
TripleTOF 6600 (1)
Gas Chromatography MS - - - Liquid Chromatography MS - - - Gas Chromatography MS - positive (1)
Liquid Chromatography MS - (1)

Publication Date

2010 (43)
2012 (35)
2015 (33)
2011 (27)
2014 (24)
2013 (22)
2025 (19)
2008 (19)
2021 (17)
2016 (17)
2024 (16)
2019 (12)
2026 (10)
2022 (10)
2017 (10)
2009 (9)
2018 (7)
2020 (7)
2023 (5)
2005 (4)
2007 (3)
2006 (2)

UNIPROT ID/AC

O96020 (1)
P01106 (1)
P06400 (1)
P07490 (1)
P24864 (1)
P30969 (1)
P51924 (1)
Q01094 (1)

CHEBI ID

CHEBI:15428 (3)
CHEBI:17822 (3)
CHEBI:17368 (3)
CHEBI:17568 (3)
CHEBI:14314 (2)
CHEBI:15354 (2)
CHEBI:15940 (2)
CHEBI:16040 (2)
CHEBI:16235 (2)
CHEBI:16313 (2)
CHEBI:16449 (2)
CHEBI:16704 (2)
CHEBI:16737 (2)
CHEBI:16742 (2)
CHEBI:16750 (2)
CHEBI:16811 (2)
CHEBI:15633 (1)
CHEBI:15635 (1)
CHEBI:15637 (1)
CHEBI:15638 (1)
CHEBI:15641 (1)
CHEBI:16474 (1)
CHEBI:16595 (1)
CHEBI:17230 (1)
CHEBI:17622 (1)
CHEBI:18272 (1)
CHEBI:18406 (1)
CHEBI:1989 (1)
CHEBI:24367 (1)
CHEBI:30751 (1)

Metabolite Name

GAR (2)
Uracil (2)
1-Naphthaleneacetic acid (1)
1-methyladenosine (1)
1-methylnicotinamide (1)
12-Methyltridecanoic acid (1)
16-Methylheptadecanoic acid (1)
2,3-BPG (1)
2-Hydroxybutyric acid (AHB) (1)
2-Hydroxystearic acid (1)
2-Indolecarboxylic acid (1)
2-Ketobutyric acid (1)
2-aminoadipate (1)
2-hydroxyglutarate (1)
2-oxoadipate (1)
3-hydroxybutyrate (1)
3-hydroxyisobutyric acid (1)
3-methylglutarylcarnitine (1)
3-phosphoglycerate (1)
3-ureidopropionate (1)
4-Guanidinobutanoic acid (1)
4-Hydroxybutyric acid (1)
4-Methylcatechol (1)
5-Hydroxyindole-3-Acetate (1)
6-phosphogluconate (1)
7-methylguanosine (1)
ADP (1)
ADP-ribose (1)
AICAR (1)
AMP (1)

First Public Date

2014 (17)
2020 (13)
2025 (11)
2015 (10)
2026 (9)
2024 (9)
2022 (8)
2021 (7)
2013 (6)
2017 (5)
2018 (4)
2019 (3)
2023 (2)
2016 (2)

Modelling Approach

Ordinary differential equation model (5)

Study status

Recruiting (1)

Lab affiliation

North Carolina State University (6)
Duke University Eye Center (3)
Assistant Professor Department of Medicine, Division of Endocrinology, Metabolism, and Nutrition Department of Pharmacology and Cancer Biology Duke University Medical Center (2)
Cardiovascular and Metabolic Diseases, Duke-NUS Medical School, Singapore (2)
Department of Pathology and Duke Cancer Institute, Duke University School of Medicine, Durham, NC 27710, USA (2)
Duke University (2)
Professor, Chemistry, Duke University (2)
Professor, Department of Chemistry, Duke University, USA (2)
1 Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA. 2 Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710, USA 3 Duke Cancer Institute, Duke University School of Medicine, Durham, NC 27710, USA 4 Department of Pathology, Duke University School of Medicine, Durham, NC 27710, USA (1)
Assistant Professor of Biochemistry Assistant Professor in Neurobiology Nanaline Duke Room 155 Box 3711, DUMC Durham, NC 27710 (1)
Assistant Professor of Biochemistry Assistant Professor of Neurobiology Nanaline Duke Room 155 Box 3711, DUMC Durham, NC 27710 (1)
Associate Professor Department of Biochemistry Duke University School of Medicine (1)
Associate Professor of Biochemistry Associate Professor of Cell Biology Duke University School of Medicine (1)
Associate Professor of Oncological Sciences Huntsman Cancer Institute at the University of Utah (1)
Associate Professor, Department of Medicine, Division of Endocrinology, Metabolism, and Nutrition, Department of Pharmacology and Cancer Biology Duke University Medical Center (1)
Centre for Bioinnovation, University of the Sunshine Coast (1)
Chair, Department of Molecular Genetics and Microbiology James B. Duke Distinguished Professor of Molecular Genetics and Microbiology Duke University School of Medicine (1)
Chemistry Department, Duke University, Durham, NC, 27705, USA (1)
Chemistry, Duke University (1)
Chemistry, Duke University, USA (1)
Chemistry, Fitzgerald, Duke University, USA (1)
Chemistry, Fitzgerald, Duke university, USA (1)
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, United States (1)
Department of Chemistry, Duke University Durham, North Carolina (1)
Department of Integrated Immunobiology Duke School of Medicine Durham, NC, USA (1)
Department of Integrated Immunobiology Duke School of Medicine Durham, NC, USA (1)
Department of Pharmacology and Cancer Biology Duke University School of Medicine Durham, North Carolina (1)
Departments of Chemistry and Biochemistry, Duke University, United States (1)
Director of Basic Research, Duke Molecular Physiology Institute Professor, Department of Medicine, Duke University Medical Center (1)
Director, Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center Professor Departments of Medicine (Division of Endocrinology, Metabolism, and Nutrition) and Pharmacology & Cancer Biology Duke University Medical Center (1)

IsPrivate

False (5)

Submitter Keywords

Immuno-oncology (1)

Classification

bacteria (1)
fungi (1)

Study type

Transcription profiling by array (171)
RNA-seq of coding RNA (23)
ChIP-seq (21)
Unknown experiment type (9)
Other (5)
Methylation profiling by array (5)
DNA-seq (4)
Comparative genomic hybridization by array (3)
Methylation profiling by high throughput sequencing (2)
Transcription profiling by SAGE (1)
High-throughput sequencing (1)
Transcription profiling by tiling array (1)
MicroRNA profiling by array (1)
Proteomic profiling by array (1)
Genotyping by high throughput sequencing (1)
RNA-seq of coding RNA from single cells (1)
Interventional (1)

Release Date

2022 (905)
2021 (886)
2025 (848)
2023 (819)
2024 (782)
2020 (726)
2019 (590)
2018 (513)
2017 (487)
2016 (448)
2015 (433)
2014 (349)
2013 (229)
2012 (197)
2011 (192)
2010 (183)
2026 (118)
2009 (98)
2008 (96)
2007 (40)
2006 (23)
2005 (21)
2003 (14)
2004 (12)
1999 (8)
2002 (7)
2001 (4)
2000 (3)
1998 (1)

Location

China (1)
Hong Kong (1)
India (1)
Indonesia (1)
Malaysia (1)
Philippines (1)
Saudi Arabia (1)
Singapore (1)
Taiwan (1)
Thailand (1)

Previous page
1 / 928
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 928
Next page

Sort by:

Relevance

Page size

Pediatric T cell and B cell responses to SARS-CoV-2 infection.

Not available

S-EPMC12581660 | biostudies-literature

Phase III, Multi-centre, Double Blind, Randomized Placebo Controlled Trial of Aspirin for Duke C and High Risk Dukes B Colorectal Cancers

Intervention1: Aspirin: 200 mg OD for 3 years Control Intervention1: Placebo: 200 mg OD for 3 years Primary outcome(s): 1. Disease free survival for all eligible subjects (high risk Dukes B colon cancer, Dukes C colon cancer and rectal cancer ptient sub groups)Timepoint: 3 years;Disease free surviva...

2572425 | ecrin-mdr-crc

Gene expression profiles regulated by Stat5a/b vs. Stat3 in human prostate cancer cells.

Identification of the molecular changes that promote viability and metastatic behaviour of prostate cancer cells is critical for the development of improved therapeutic interventions for prostate cancer. Stat5a/b and Stat3 are both constitutively active in locally-confined and advanced prostate canc...

ORGANISM(S): Homo sapiens

2010-05-27 | E-GEOD-17482 | biostudies-arrayexpress

Murine germinal center and naive B cells

Gene expressions of murine germinal center and naive B cells on Affymetrix platform The experiment include 3 d14 GC B1-8, 3 d14 GC V23 and 4 NaM-CM-/ve samples

ORGANISM(S): Mus musculus

2013-03-06 | E-GEOD-44260 | biostudies-arrayexpress

Single-cell RNA sequencing analysis of blood B cells from human allogeneic hematopoietic transplant patients

PRJNA677928 | ENA

Hanson2016 - Toxicity Management in CAR T cell therapy for B-ALL

This model provides an in silico mathematical platform to explore the interactions between chimeric antigen receptor-modified T cells, inflammatory toxicitiy, and the tumour burdens of individual patients.

2024-09-02 | BIOMD0000000837 | BioModels

Immuno-oncology